---
title: "Biophytis changes Hexagon bond facility to make it revolving"
url: "https://aibio.space/news/biophytis-changes-hexagon-bond-facility-make-revolving/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-05-27"
section: "Debt Financing"
tickers: "EURONEXT:ALBPS"
source: "https://www.biophytis.com/en/biophytis-changes-its-financing-agreement-with-hexagon-capital-fund-to-ensure-its-e2-million-facility-is-renewable/"
summary: "Biophytis amended its straight bond financing with Hexagon Capital Fund a second time, making the facility revolving and reducing its cost."
---

By the aibio.space news desk.

Sources

- [Biophytis SA release (2026-05-27)](https://www.biophytis.com/en/biophytis-changes-its-financing-agreement-with-hexagon-capital-fund-to-ensure-its-e2-million-facility-is-renewable/)

[ALBPS](https://aibio.space/companies/biophytis/)

2026-05-27

# Biophytis changes Hexagon bond facility to make it revolving

Tickers [ALBPS](https://aibio.space/companies/biophytis/)

Biophytis amended its straight bond financing with Hexagon Capital Fund a second time, making the facility revolving and reducing its cost.

## Key facts

- **Company**: Biophytis SA (EURONEXT: ALBPS)

- **News type**: Debt Financing

- **Primary source**: [Biophytis SA release (2026-05-27)](https://www.biophytis.com/en/biophytis-changes-its-financing-agreement-with-hexagon-capital-fund-to-ensure-its-e2-million-facility-is-renewable/)

*A distant skyline over open water. Photo: Matt Bango, CC0, via StockSnap. The picture shows the field, not the companies named.*

Biophytis SA changed the terms of a straight bond financing facility established with Hexagon Capital Fund on August 5, 2025. The facility was first amended on February 26, 2026, and amended a second time on May 22, 2026. The company announced the latest changes in a release dated May 27, 2026.

According to the release, the changes make the facility revolving and reduce its cost. The company says the changes are part of its strategy to optimize its financial structure and secure the resources needed to achieve its clinical ambitions.

CEO Stanislas Veillet said: "By making this facility revolving and reducing its cost, we are giving ourselves valuable flexibility to finance our next steps under the best conditions." He described the adjustments as active and disciplined financial management in support of the strategy.

The release does not give the new amounts or the new rate, and it does not say whether the changes add new money. Hexagon Capital Fund is the lender on the facility. The release names no placement agent or advisor.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

ALBPS

Biophytis SA

EURONEXT · France

Open the starter desk

## More in Debt Financing

Debt Financing

### [Pelthos amends Horizon venture loan, funds Loans E to H and adds Loans I and J](https://aibio.space/news/pelthos-amends-horizon-venture-loan-funds-loans-e-h-adds-loans/)

Oct 30, 2026

Debt Financing

### [Repligen announces $1.0 billion private convertible notes transaction](https://aibio.space/news/repligen-announces-1-0-billion-private-convertible-notes-transaction/)

Oct 30, 2026

Debt Financing

### [FOXO to buy Ludwig Enterprises preferred stock with majority voting power](https://aibio.space/news/foxo-buy-ludwig-enterprises-preferred-stock-majority-voting-power/)

Oct 29, 2026

---
Source page: https://aibio.space/news/biophytis-changes-hexagon-bond-facility-make-revolving/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Biophytis changes Hexagon bond facility to make it revolving", 2026-05-27, https://aibio.space/news/biophytis-changes-hexagon-bond-facility-make-revolving/